TANABE PHARMA
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79428704
- Mark type
- Design + words
- Filed
- 22 May 2025
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Jeffrey L. Costellia
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders
Owner
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Mar 2026 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 18 Dec 2025 — REFUSAL PROCESSED BY IB
- 28 Nov 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 28 Nov 2025 — REFUSAL PROCESSED BY MPU
- 11 Oct 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 10 Oct 2025 — NON-FINAL ACTION WRITTEN